AI Analysis

How does ASCLF make money? Does ASCLF have pricing power? What's the Earnings Whisper? Will ASCLF profit more as the business scales? What is ASCLF's management track record? Is ASCLF's current price justified?

Ascletis Pharma Inc.

$1.21 -$0.28 (-18.79%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$1.3

Day Range

$1.21$1.3

Year Range

$1.07$2.5

Market Cap

1.27B

AVG Volume

1.08K

Trailing/Forward PE

-13/-

PEG ratio

-0.58

Dividend Yield

Next Earnings Date

2027-03-30

Primary Exchange

Other OTC

Free Cash Flow Yield

ASCLF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-9.13%
Sep 26	-8.5%
Aug 26	-8.48%
Aug 26	-8.49%
Aug 26	-8.21%
Aug 26	-9.08%
Jul 26	-10.26%
Jul 26	-7.71%
Jul 26	-7.71%
Jul 26	-7.6%
Jul 26	-8.09%
Jun 26	-8.08%
Jun 26	-8.11%
Jun 26	-8.12%
Jun 26	-8.3%
May 26	-6.56%
May 26	-6.53%
May 26	-5.09%
May 26	-5.09%
May 26	-5.05%
Apr 26	-4.45%
Apr 26	-5.18%
Apr 26	-5.17%
Apr 26	-5.95%
Mar 26	-4.96%
Mar 26	-4.98%
Mar 26	-4.64%
Mar 26	-4.59%
Feb 26	-4.17%
Feb 26	-3.97%
Feb 26	-4.28%
Feb 26	-5.11%
Jan 26	-5.1%
Jan 26	-5.09%
Jan 26	-5.03%
Jan 26	-5.81%
Jan 26	-5.96%
Dec 25	-5.18%
Dec 25	-5.15%
Dec 25	-4.33%
Dec 25	-5.04%
Nov 25	-4.96%
Nov 25	-4.93%
Nov 25	-5.71%
Nov 25	-7.64%
Oct 25	-7.27%
Oct 25	-7.26%
Oct 25	-7.14%
Oct 25	-7.13%
Oct 25	-7.14%
Sep 25	-5.01%
Sep 25	-4.57%
Sep 25	-4.56%
Sep 25	-3.69%
Aug 25	-3.7%
Aug 25	-3.68%
Aug 25	-3.67%
Aug 25	-5.4%
Aug 25	-5.03%
Jul 25	-5.06%
Jul 25	-5.06%
Jul 25	-5.59%
Jul 25	-5.59%
Jun 25	-7.49%
Jun 25	-7.5%
Jun 25	-7.48%
Jun 25	-7.47%
May 25	-7.46%
May 25	-7.81%
May 25	-8.19%
May 25	-8.16%
May 25	-8.46%
Apr 25	-7.83%
Apr 25	-11.03%
Apr 25	-11.05%
Apr 25	-5.73%
Mar 25	-5.18%
Mar 25	-5.99%
Mar 25	-6%
Mar 25	-6.75%
Feb 25	-7.39%
Feb 25	-7.42%
Feb 25	-26%
Feb 25	-25.88%
Jan 25	-26.01%
Jan 25	-26.04%
Jan 25	-25.75%
Jan 25	-25.72%
Jan 25	-25.77%
Dec 24	-25.84%
Dec 24	-25.85%
Dec 24	-35.39%
Dec 24	-35.41%
Nov 24	-35.55%
Nov 24	-35.53%
Nov 24	-29.72%
Nov 24	-33.98%
Nov 24	-40.44%
Oct 24	-40.45%
Oct 24	-40.56%

Price to Sales

ASCLF Price to Sales by year
Period	Price to Sales
Sep 26	2403.2
Sep 26	2583.22
Aug 26	2588.87
Aug 26	2586.95
Aug 26	2674.56
Aug 26	2417.24
Jul 26	2138.89
Jul 26	2847.15
Jul 26	2848.87
Jul 26	2889.25
Jul 26	2713.47
Jun 26	2717.23
Jun 26	2705.48
Jun 26	2703.08
Jun 26	2644.14
May 26	3345.59
May 26	3359.58
May 26	4314.72
May 26	4308.89
May 26	4346.09
Apr 26	4938.52
Apr 26	4238.55
Apr 26	4245.33
Apr 26	3690.05
Mar 26	966.78
Mar 26	963.16
Mar 26	1033.89
Mar 26	1044.61
Feb 26	1150.06
Feb 26	1206.51
Feb 26	1121.1
Feb 26	938.48
Jan 26	940.06
Jan 26	941.7
Jan 26	953.14
Jan 26	824.98
Jan 26	805.24
Dec 25	925.88
Dec 25	930.44
Dec 25	1106.76
Dec 25	950.71
Nov 25	967.77
Nov 25	972.09
Nov 25	839.41
Nov 25	627.44
Oct 25	660
Oct 25	660.39
Oct 25	671.9
Oct 25	672.61
Oct 25	671.2
Sep 25	170.24
Sep 25	186.79
Sep 25	187.03
Sep 25	231.02
Aug 25	230.96
Aug 25	232.08
Aug 25	232.62
Aug 25	157.98
Aug 25	169.66
Jul 25	168.63
Jul 25	168.86
Jul 25	152.75
Jul 25	152.76
Jun 25	114.01
Jun 25	113.81
Jun 25	114.16
Jun 25	114.28
May 25	114.44
May 25	109.31
May 25	104.19
May 25	104.59
May 25	100.95
Apr 25	109.02
Apr 25	77.36
Apr 25	77.28
Apr 25	148.95
Mar 25	122.23
Mar 25	105.73
Mar 25	105.57
Mar 25	93.79
Feb 25	85.68
Feb 25	85.3
Feb 25	24.34
Feb 25	24.46
Jan 25	24.33
Jan 25	24.31
Jan 25	24.58
Jan 25	24.61
Jan 25	24.57
Dec 24	24.49
Dec 24	24.49
Dec 24	17.89
Dec 24	17.87
Nov 24	17.81
Nov 24	17.81
Nov 24	21.3
Nov 24	18.63
Nov 24	15.65
Oct 24	15.65
Oct 24	15.61

Price to Book

ASCLF Price to Book by year
Period	Price to Book
Sep 26	4.09
Sep 26	4.4
Aug 26	4.41
Aug 26	4.4
Aug 26	4.55
Aug 26	4.12
Jul 26	3.64
Jul 26	4.85
Jul 26	4.85
Jul 26	4.92
Jul 26	4.62
Jun 26	4.63
Jun 26	4.61
Jun 26	4.6
Jun 26	4.5
May 26	5.7
May 26	5.72
May 26	7.35
May 26	7.34
May 26	7.4
Apr 26	8.41
Apr 26	7.22
Apr 26	7.23
Apr 26	6.28
Mar 26	6.45
Mar 26	6.42
Mar 26	6.89
Mar 26	6.97
Feb 26	7.67
Feb 26	8.04
Feb 26	7.48
Feb 26	6.26
Jan 26	6.27
Jan 26	6.28
Jan 26	6.36
Jan 26	5.5
Jan 26	5.37
Dec 25	6.17
Dec 25	6.2
Dec 25	7.38
Dec 25	6.34
Nov 25	6.45
Nov 25	6.48
Nov 25	5.6
Nov 25	4.18
Oct 25	4.4
Oct 25	4.4
Oct 25	4.48
Oct 25	4.48
Oct 25	4.48
Sep 25	5.01
Sep 25	5.5
Sep 25	5.51
Sep 25	6.8
Aug 25	6.8
Aug 25	6.83
Aug 25	6.85
Aug 25	4.65
Aug 25	4.99
Jul 25	4.96
Jul 25	4.97
Jul 25	4.5
Jul 25	4.5
Jun 25	3.36
Jun 25	3.35
Jun 25	3.36
Jun 25	3.36
May 25	3.37
May 25	3.22
May 25	3.07
May 25	3.08
May 25	2.97
Apr 25	3.21
Apr 25	2.28
Apr 25	2.27
Apr 25	4.38
Mar 25	4.06
Mar 25	3.51
Mar 25	3.51
Mar 25	3.12
Feb 25	2.85
Feb 25	2.84
Feb 25	0.81
Feb 25	0.81
Jan 25	0.81
Jan 25	0.81
Jan 25	0.82
Jan 25	0.82
Jan 25	0.82
Dec 24	0.81
Dec 24	0.81
Dec 24	0.59
Dec 24	0.59
Nov 24	0.59
Nov 24	0.59
Nov 24	0.71
Nov 24	0.62
Nov 24	0.52
Oct 24	0.52
Oct 24	0.52

No video analysis for this stock yet. Request one from our team.

News: ASCLF

prnewswire.com · 23 Jun 2026

Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity

Phase I trial consists of two parts. Part A is a single ascending dose (SAD) study of ASC35 once-monthly Self-Assembling Lipid Depot (SALD) formulation; Part B is a head-to-head study of multiple ascending doses (MAD) of ASC35 once-monthly SALD formulation compared to the U.S. Food and Drug Administration (FDA)-authorized tirzepatide once-weekly formulation.

AI Analysis

Ascletis Pharma Inc.

Video analysis: ASCLF

News: ASCLF

Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity

Similar companies